Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
Dexcom, Inc
(https://dexcom.com) 📸 Data Snapshot: May 29, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Dexcom Continuous Glucose Monitoring – The most accurate CGM system1 | Dexcom (https://dexcom.com)
Title
Dexcom Continuous Glucose Monitoring – The most accurate CGM system1 | Dexcom
Meta
Dexcom Continuous Glucose Monitoring is simplifying diabetes management with a small device, accurate real-time glucose readings, and proven results. No fingersticks or scanning.†
H2 Relentless innovation from the leaders in glucose health
H2 Dexcom G7 and Dexcom G7 15 Day—the world's most powerful CGM systems1
H2 Stelo Glucose Biosensor
H2 Empowering people to take control of health
H3 Get Started with Dexcom
HEADING_REPEATED_BODY International | Dexcom | Dexcom (https://dexcom.com/global/)
Title
International | Dexcom | Dexcom
Meta
International | Dexcom
NAV_HEADING_REPEATED_BODY Dexcom Continuous Glucose Monitoring – The most accurate CGM system1 | Dexcom (https://dexcom.com/en-us/)
Title
Dexcom Continuous Glucose Monitoring – The most accurate CGM system1 | Dexcom
Meta
Dexcom Continuous Glucose Monitoring is simplifying diabetes management with a small device, accurate real-time glucose readings, and proven results. No fingersticks or scanning.†
H2 Relentless innovation from the leaders in glucose health
H2 Dexcom G7 and Dexcom G7 15 Day—the world's most powerful CGM systems1
H2 Stelo Glucose Biosensor
H2 Empowering people to take control of health
H3 Get Started with Dexcom
HEADING_REPEATED_BODY About Dexcom Glucose Sensing and CGM Company | Dexcom (https://dexcom.com/en-us/about-dexcom/)
Title
About Dexcom Glucose Sensing and CGM Company | Dexcom
Meta
Dexcom is a leading glucose sensing and continuous glucose monitoring (CGM) manufacturer for diabetes management. Learn about Dexcom, their mission and values.
H1 Who we are
H2 Corporate sustainability
H2 Game-changing technology, life-changing work
H2 Leading with purpose
H2 Learn more about our products
H2 Dexcom in the spotlight
H4 Lance Bass spotlights Dexcom G7 in this interview with Yahoo news
H4 CNBC introduces Stelo—the first over-the-counter CGM
H4 Dexcom G7’s direct-to-watch feature explained by CNET
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://dexcom.com) Dexcom Continuous Glucose Monitoring – The most accurate CGM system1 | Dexcom
Dexcom Receiver Users: Medical Device Correction, click here for important information [H2] Relentless innovation from the leaders in glucose health Dexcom has set the standard in glucose biosensing for 25 years and counting. Our best-in-class technologies empower people to know what is happening in their bodies in real time, helping them to better understand the many factors that impact their glucose and overall health.Smart devices sold separately.‡Explore our portfolio [IMG: two people smiling in the park one wearing the Dexcom G7 sensor] [IMG: Dexcom G7 sensor] [H2] Dexcom G7 and Dexcom G7 15 Day—the world's most powerful CGM systems1 Dexcom G7 CGM Systems deliver proven results2-6 with best-in-class accuracy1 and a growing ecosystem of connected partners that help ease the burden of living with diabetes. They’re designed for all types of diabetes, sending glucose numbers to your phone‡ or receiver in real time, giving you the knowledge to better control diabetes for healthier tomorrows.7,8Explore Dexcom G7 [IMG: Man walking outside while wearing Stelo sensor] [IMG: Stelo sensor] [H2] Stelo Glucose Biosensor The power to personalize your diet and exercise choices starts with Stelo. It sends personal glucose insights right to your phone,‡ giving you all the information you need to make healthier habits become second nature. No prescription. No fingersticks, ever. Just results.Learn more [IMG: Woman walking with a friend outside while wearing sensor] [H2] Empowering people to take control of health Since 1999, Dexcom has been developing innovative technology that has transformed how people manage diabetes and track their glucose. We think of ourselves as partners in their journey, empowering them to live confidently and take control of their health with our life-changing products.More about Dexcom [H3] [H3] Get Started with Dexcom Take the first step towards better health! Glucose health is a critical part of overall health, and Dexcom has the best sensing solution for you or your loved one regardless of your health goals. We'll make getting started easy from the comfort of your home. *A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days. †Excludes implantable CGM systems. ‡For Dexcom G7 compatible devices, visit dexcom.com/compatibility. For Stelo app compatibility information, visit stelo.com/compatibility. 1 Dexcom, Data on file, 2025. 2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Garg SK, et al. Diabetes Technol Ther. 2025;27(6):413-502. 6 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 7 Ehrhardt N, et al. Clin Diabetes. 2020:38(2):126-131. 8 Clark TL, et al. Diabetes Technol Ther. 2024;26(10):700-8. BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency. INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.MAT-4823
5290 chars
SUB-PAGE (https://dexcom.com/global/) International | Dexcom | Dexcom
Choose your country or regionChoose your country or region [IMG: Andorra flag] AndorraEspañol [IMG: Argentina flag] ArgentinaEspañol [IMG: Australia flag] AustraliaEnglish [IMG: Bahrain flag] BahrainEnglish [IMG: Belgien flag] BelgienDeutsch [IMG: Belgique flag] BelgiqueFrançais [IMG: België flag] BelgiëNederlands [IMG: Canada flag] CanadaEnglish [IMG: Canada flag] CanadaFrançais [IMG: Danmark flag] DanmarkDansk [IMG: Deutschland flag] DeutschlandDeutsch [IMG: Eesti flag] EestiEesti [IMG: España flag] EspañaEspañol [IMG: Estonia flag] EstoniaEnglish [IMG: Finland flag] FinlandSvenska [IMG: France flag] FranceFrançais [IMG: Hong Kong flag] Hong KongEnglish [IMG: Hrvatska flag] HrvatskaHrvatski [IMG: Iceland flag] IcelandEnglish [IMG: Ireland flag] IrelandEnglish [IMG: Israel flag] IsraelEnglish [IMG: Italia flag] ItaliaItaliano [IMG: Jordan flag] JordanEnglish [IMG: Kuwait flag] KuwaitEnglish [IMG: Latvija flag] LatvijaLatviešu [IMG: Lebanon flag] LebanonEnglish [IMG: Lietuva flag] LietuvaLietuvių [IMG: Luxembourg flag] LuxembourgFrançais [IMG: Luxemburg flag] LuxemburgDeutsch [IMG: Magyarország flag] MagyarországMagyar [IMG: Malaysia flag] MalaysiaEnglish [IMG: Malta flag] MaltaEnglish [IMG: Nederland flag] NederlandNederlands [IMG: New Zealand flag] New ZealandEnglish [IMG: Norge flag] NorgeNorsk [IMG: Oman flag] OmanEnglish [IMG: Polska flag] PolskaPolski [IMG: Portugal flag] PortugalPortuguês [IMG: Qatar flag] QatarEnglish [IMG: România flag] RomâniaRomână [IMG: Saudi Arabia flag] Saudi ArabiaEnglish [IMG: Schweiz flag] SchweizDeutsch [IMG: Singapore flag] SingaporeEnglish [IMG: Slovenia flag] SloveniaSlovenski [IMG: Slovenská Republika flag] Slovenská RepublikaSlovenský [IMG: South Africa flag] South AfricaEnglish [IMG: Suisse flag] SuisseFrançais [IMG: Suomi flag] SuomiSuomalainen [IMG: Sverige flag] SverigeSvenska [IMG: Svizzera flag] SvizzeraItaliano [IMG: Türkiye flag] TürkiyeTürkçe [IMG: United Arab Emirates flag] United Arab EmiratesEnglish [IMG: United Kingdom flag] United KingdomEnglish [IMG: United States flag] United StatesEnglish [IMG: Estados Unidos flag] Estados UnidosEspañol [IMG: Österreich flag] ÖsterreichDeutsch [IMG: Česká Republika flag] Česká RepublikaCeský [IMG: Ελλάδα flag] Ελλάδαελληνικά [IMG: България flag] БългарияБългарски [IMG: ישראל flag] ישראלעִברִית [IMG: إسرائيل flag] إسرائيلعربى [IMG: الأردن flag] الأردنعربى [IMG: الإمارات العربية المتحدة flag] الإمارات العربية المتحدةعربى [IMG: البحرين flag] البحرينعربى [IMG: الكويت flag] الكويتعربى [IMG: المملكة العربية السعودية flag] المملكة العربية السعوديةعربى [IMG: دولة قطر flag] دولة قطرعربى [IMG: سلطنة عمان flag] سلطنة عمانعربى [IMG: لبنان flag] لبنانعربى [IMG: 日本 flag] 日本日本語 [IMG: 대한민국 flag] 대한민국한국어
2725 chars
SUB-PAGE (https://dexcom.com/en-us/) Dexcom Continuous Glucose Monitoring – The most accurate CGM system1 | Dexcom
Dexcom Receiver Users: Medical Device Correction, click here for important information [H2] Relentless innovation from the leaders in glucose health Dexcom has set the standard in glucose biosensing for 25 years and counting. Our best-in-class technologies empower people to know what is happening in their bodies in real time, helping them to better understand the many factors that impact their glucose and overall health.Smart devices sold separately.‡Explore our portfolio [IMG: two people smiling in the park one wearing the Dexcom G7 sensor] [IMG: Dexcom G7 sensor] [H2] Dexcom G7 and Dexcom G7 15 Day—the world's most powerful CGM systems1 Dexcom G7 CGM Systems deliver proven results2-6 with best-in-class accuracy1 and a growing ecosystem of connected partners that help ease the burden of living with diabetes. They’re designed for all types of diabetes, sending glucose numbers to your phone‡ or receiver in real time, giving you the knowledge to better control diabetes for healthier tomorrows.7,8Explore Dexcom G7 [IMG: Man walking outside while wearing Stelo sensor] [IMG: Stelo sensor] [H2] Stelo Glucose Biosensor The power to personalize your diet and exercise choices starts with Stelo. It sends personal glucose insights right to your phone,‡ giving you all the information you need to make healthier habits become second nature. No prescription. No fingersticks, ever. Just results.Learn more [IMG: Woman walking with a friend outside while wearing sensor] [H2] Empowering people to take control of health Since 1999, Dexcom has been developing innovative technology that has transformed how people manage diabetes and track their glucose. We think of ourselves as partners in their journey, empowering them to live confidently and take control of their health with our life-changing products.More about Dexcom [H3] [H3] Get Started with Dexcom Take the first step towards better health! Glucose health is a critical part of overall health, and Dexcom has the best sensing solution for you or your loved one regardless of your health goals. We'll make getting started easy from the comfort of your home. *A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days. †Excludes implantable CGM systems. ‡For Dexcom G7 compatible devices, visit dexcom.com/compatibility. For Stelo app compatibility information, visit stelo.com/compatibility. 1 Dexcom, Data on file, 2025. 2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Garg SK, et al. Diabetes Technol Ther. 2025;27(6):413-502. 6 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 7 Ehrhardt N, et al. Clin Diabetes. 2020:38(2):126-131. 8 Clark TL, et al. Diabetes Technol Ther. 2024;26(10):700-8. BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency. INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.MAT-4823
5290 chars
SUB-PAGE (https://dexcom.com/en-us/about-dexcom/) About Dexcom Glucose Sensing and CGM Company | Dexcom
[H1] Who we are Dexcom empowers people to take control of health through innovative glucose biosensing technology. For more than 25 years, our technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. [H2] Corporate sustainability Sustainability is at the heart of everything we do. From reducing our environmental impact to advancing access to our life-changing technology, there are so many initiatives that we’d like to share with you. Read our annual sustainability report to learn more. Sustainability report [H2] Game-changing technology, life-changing work A career with Dexcom is an opportunity to do work that can change people’s lives while having the support to develop professionally. Learn more about our company, culture, and current openings. Dexcom careers [H2] Leading with purpose Dexcom leaders are defining the next era in biosensing while shaping a culture that brings out the best in our people.Meet our leaders [H2] Learn more about our products Our products give people the knowledge they need to gain control of their glucose and achieve better health. Explore our products and see what’s right for you.Dexcom products [H2] Dexcom in the spotlight [H4] Lance Bass spotlights Dexcom G7 in this interview with Yahoo news Using the Dexcom G7 continuous glucose monitor has taken the guesswork out of that process as well. “Every five minutes, I get a new reading and see exactly where my glucose is,” he says.Read full article [H4] CNBC introduces Stelo—the first over-the-counter CGM “The idea is to help people, over time, learn about diet choices and habits, and how those are impacting glucose,” Jake Leach, chief operating officer at Dexcom, told CNBC in an interview. Read full article [H4] Dexcom G7’s direct-to-watch feature explained by CNET In a first, the direct-to-watch feature gives Dexcom users of continuous glucose monitors information and alerts without being in range of their phone. Read full article*To see a list of compatible devices, visit dexcom.com/compatibility.
2097 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
9Review mentions (all pages)
3External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 1 |
| /global/ | 1 | 0 |
| /en-us/ | 2 | 1 |
| /en-us/about-dexcom/ | 4 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
[
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://www.dexcom.com",
"legalName": "Dexcom, Inc",
"logo": "https://www.dexcom.com/sites/all/themes/dexcom/images/svg/Logo.svg",
"name": "Dexcom",
"sameAs": [
"https://www.facebook.com/dexcom",
"https://www.instagram.com/dexcom",
"https://www.linkedin.com/company/dexcom",
"https://www.youtube.com/channel/UCCY5ydvJD6932sh4XQGifxQ"
],
"url": "https://www.dexcom.com",
"address": {
"@type": "PostalAddress",
"streetAddress": "6290 Sequence Dr",
"addressLocality": "San Diego",
"addressRegion": "California",
"postalCode": "92121",
"addressCountry": "US"
},
"contactPoint": [
{
"@type": "ContactPoint",
"telephone": "+1-888-738-3646",
"contactType": "customer service"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebSite",
"url": "https://www.dexcom.com",
"potentialAction": [
{
"@type": "SearchAction",
"target": "https://www.dexcom.com/search?q={search_term_string}",
"query-input": "required name=search_term_string"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebPage",
"@id": "https://www.dexcom.com/en-us",
"description": "Dexcom Continuous Glucose Monitoring is simplifying diabetes management with a small device, accurate real-time glucose readings, and proven results. No fingersticks or scanning.†"
}
]
/global/
[
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://www.dexcom.com",
"legalName": "Dexcom, Inc",
"logo": "https://www.dexcom.com/sites/all/themes/dexcom/images/svg/Logo.svg",
"name": "Dexcom",
"sameAs": [
"https://www.facebook.com/dexcom",
"https://www.instagram.com/dexcom",
"https://www.linkedin.com/company/dexcom",
"https://www.youtube.com/channel/UCCY5ydvJD6932sh4XQGifxQ"
],
"url": "https://www.dexcom.com",
"address": {
"@type": "PostalAddress",
"streetAddress": "6290 Sequence Dr",
"addressLocality": "San Diego",
"addressRegion": "California",
"postalCode": "92121",
"addressCountry": "US"
},
"contactPoint": [
{
"@type": "ContactPoint",
"telephone": "+1-888-738-3646",
"contactType": "customer service"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebSite",
"url": "https://www.dexcom.com",
"potentialAction": [
{
"@type": "SearchAction",
"target": "https://www.dexcom.com/search?q={search_term_string}",
"query-input": "required name=search_term_string"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebPage",
"@id": "https://www.dexcom.com/en-us/global",
"description": "International | Dexcom"
}
]
/en-us/
[
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://www.dexcom.com",
"legalName": "Dexcom, Inc",
"logo": "https://www.dexcom.com/sites/all/themes/dexcom/images/svg/Logo.svg",
"name": "Dexcom",
"sameAs": [
"https://www.facebook.com/dexcom",
"https://www.instagram.com/dexcom",
"https://www.linkedin.com/company/dexcom",
"https://www.youtube.com/channel/UCCY5ydvJD6932sh4XQGifxQ"
],
"url": "https://www.dexcom.com",
"address": {
"@type": "PostalAddress",
"streetAddress": "6290 Sequence Dr",
"addressLocality": "San Diego",
"addressRegion": "California",
"postalCode": "92121",
"addressCountry": "US"
},
"contactPoint": [
{
"@type": "ContactPoint",
"telephone": "+1-888-738-3646",
"contactType": "customer service"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebSite",
"url": "https://www.dexcom.com",
"potentialAction": [
{
"@type": "SearchAction",
"target": "https://www.dexcom.com/search?q={search_term_string}",
"query-input": "required name=search_term_string"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebPage",
"@id": "https://www.dexcom.com/en-us",
"description": "Dexcom Continuous Glucose Monitoring is simplifying diabetes management with a small device, accurate real-time glucose readings, and proven results. No fingersticks or scanning.†"
}
]
/en-us/about-dexcom/
[
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://www.dexcom.com",
"legalName": "Dexcom, Inc",
"logo": "https://www.dexcom.com/sites/all/themes/dexcom/images/svg/Logo.svg",
"name": "Dexcom",
"sameAs": [
"https://www.facebook.com/dexcom",
"https://www.instagram.com/dexcom",
"https://www.linkedin.com/company/dexcom",
"https://www.youtube.com/channel/UCCY5ydvJD6932sh4XQGifxQ"
],
"url": "https://www.dexcom.com",
"address": {
"@type": "PostalAddress",
"streetAddress": "6290 Sequence Dr",
"addressLocality": "San Diego",
"addressRegion": "California",
"postalCode": "92121",
"addressCountry": "US"
},
"contactPoint": [
{
"@type": "ContactPoint",
"telephone": "+1-888-738-3646",
"contactType": "customer service"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebSite",
"url": "https://www.dexcom.com",
"potentialAction": [
{
"@type": "SearchAction",
"target": "https://www.dexcom.com/search?q={search_term_string}",
"query-input": "required name=search_term_string"
}
]
},
{
"@context": "https://schema.org",
"@type": "WebPage",
"@id": "https://www.dexcom.com/en-us/about-dexcom",
"description": "Dexcom is a leading glucose sensing and continuous glucose monitoring (CGM) manufacturer for diabetes management. Learn about Dexcom, their mission and values."
}
]
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
✓ Less BS than average
Dexcom, Inc has 25.7 points less BS than the average for Medical Devices, Pharma & Biotech.
BS Detector
Medical Devices, Pharma & Biotech BS: Dexcom, Inc (dexcom.com)
https://dexcom.com
📍 Industry: Medical Devices, Pharma & Biotech
15
BS / 100
Dexcom provides a masterclass in low-BS medical marketing by anchoring every potentially ‘fluffy’ superlative to a specific peer-reviewed citation. The site avoids the typical ‘Health Reimagined’ trap by focusing on hardware specs, sensor longevity percentages, and clear safety warnings. It is a rare example of a site where the marketing signal is almost entirely backed by clinical substance.
Info Density
Power-words vs. Substance ratio.
7
23% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
2
10% BS
Commodity Fingerprint
Detection of industry clichés/templates.
4
27% BS
Identity & Authority
Expert verifiability & Schema depth.
1
7% BS
To achieve a score below 10, replace the vague ‘world’s most powerful’ heading with a specific performance metric such as ‘lowest MARD’ or ‘fastest warm-up time.’ Update the About page to include Person schema for the leadership team mentioned in the text to bridge the minor authority gap. Consider adding direct outbound links to the PubMed entries for the JAMA and Ann Intern Med studies cited, rather than relying on text-only footnotes. Finally, reduce the repetition of the word ’empower’ in favor of more technical descriptions of the biosensing outcomes.
The site is an archetypal fit for the Medical Device and Pharma category, heavily emphasizing regulatory safety statements and clinical trial data. The presence of ‘Indications for Use’ and specific medical contraindications confirms its status as a highly regulated healthcare entity.
“The score of 15 is primarily driven by small deductions for generic value proposition language ('empowering people') and minor identity gaps where leaders are mentioned without structured data links. The Information Density score (7) reflects the presence of some power-word headings, though they are well-supported. The site's adherence to clinical proof and transparent failure reporting prevents it from entering the 'Moderate BS' range.”
Verified Analysis Date: May 29, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from Dexcom, Inc, captured on May 29, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Dexcom, Inc: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://dexcom.com to view the most current version of its content and learn from the source what this company is about and what it offers.